Upload
ilri
View
514
Download
1
Embed Size (px)
Citation preview
Moving Bio-innovations
from the Laboratory to the Market
A Comparative Study of Four Bio-Innovate
Technological Clusters
BIPCEA
Ecuru J., Virgin, I., Omari J., Chuwa P., Teklehaimanot H., Alemu A.,Komen J., Nyange N., Ozor N., Opati
L., Karembu M., Nguthi F., Gasingirwa C.
First Bio-Innovate Regional Scientific Conference, Addis Ababa, Ethiopia, 25-27
February 2013
Outline
• Introduction
• Conceptual & methodological considerations
• Results
• Discussions and recommendations
Introduction
• Governments, stressing increased agricultural
production, value addition and agro-processing.
• There is evidence of bio-innovations in
universities & public R&D orgs, but they are
unable to move to the market.
• Moving bio-innovations to market need well
functioning innovation system;
The Study
Studies on four Bio-Innovate technological clusters with the aim to:
• Understand, from a technological innovation systems perspective, enabling conditions and barriers to moving bio-innovations from the laboratory to the market in eastern Africa
• Compare the different innovation systems and highlight similarities and dissimilarities between the four systems.
• Suggest actions and policy measures to improve the conditions for bioscience innovation in the region.
The Technological clusters include:
1. Crop improvement technologies (especially for cassava, sweet potato and potato)
2. Bio-energy and mushroom production from agro-industrial waste
3. Value added products from sorghum and millet
4. Industrial Enzymes for Sustainable Bio-Economy
The Conceptual framework
• Technological Innovation Systems (TIS) framework.
• “[…] a network or networks of agents interacting in a
specific technology area under a particular institutional
infrastructure [e.g. norms and regulation] to
generate, diffuse, and utilise technology or product.”
• TIS approach enables analysis of how different parts
of the innovation system functions.
Conceptual framework…Using seven processes to broadly map the strengths and
weaknesses of the innovation system :
1. Knowledge development and diffusion .
2. Entrepreneurial activity
3. Guidance visions, policies and strategies
4. Market creation
5. Getting legitimacy
6. Resource mobilisation
7. Positive externalities
An important part of the TIS analysis is also the
characterisation of the structural components (actors in the
system, infrastructure)
Conceptual framework…
In order to describe the strength the functions and the structural components of the innovation system, we have used a quantitative scale of 1-4,
1- Very poor. The function is fulfilled in an inadequate manner, or there are serious weaknesses.
2 - Poor. While the function is partly fulfilled, there are major weaknesses.
3 - Fair. While the function is broadly fulfilled, there are still serious weaknesses.
4 - Good. The function adequately fulfill
Study Method
Mixed methods in gathering qualitative data, based
on:
1. Review of national and regional policy
documents and institutional reports,
2. Observations
3. One focus group discussion and least five
interviews with key actors in each technological
cluster (including industry) in
Ethiopia, Kenya, Tanzania and Uganda, Rwanda
and Burundi
Results
Structural components of the
innovation system: The Actors
• From the results, it appears the actors and organizations needed to move bio-innovations to the market largely exist in the region.
• However, the actors are not interlinked to function properly.
• But, as has been seen in other related innovation systems, the number of involved actors and especially new entrants can change the dynamics of the innovation system fast.
Knowledge development
• Knowledge development in all the studied innovations
systems is at a relatively high level.
• The knowledge base is no longer a major limiting
factor in any of the four innovation systems studied.
But……
• In all the systems, marketing skills and the ability to
make assessment of economic potential of
commercialization of technologies and products is still
weak.
• Skills in developing cost effective production and
distribution regimes are also weak
Entrepreneurial activity
• The entrepreneurship skills at public R&D institutions
still limited
• Few private sector actors are investing in R&D. Close
collaboration between academia and the private sector is
not common.
• Actors in innovation consortia seldom properly
interlinked and supported to play complimentary roles.
• New entrants are making impact(especially in the case of
crop improvement/tissue culture)
Guidance/ Policies and an enabling
environment
• Science, technology and innovation(STI) policy frameworks in
place; but specific policies/regulations largely lacking.
• High taxation on imported equipment is a negative factor.
• Strategies, priority setting regimes and specific government
programmes supporting innovation still too few.
• Limited institutional structures & policies for innovation (e.g.
inst.IP policies/ management capacities to develop effective
contractual agreements, and abilities to link with market actors)
• Slow procurement procedures delaying implementation of projects
Market Creation
• Markets for all the four innovation systems are weak and affect the
four innovation systems negatively.
• Marketing techniques, marketing skills and also resources for
marketing technologies and products are to a large extent lacking
• No active market creation. Absence of focused national
goals, targets, incentives.
• As an example, in the case of biogas production unfavorable feed-
in tariffs to sell electricity generated from biogas to national
electricity grids is a negative factor.
Getting legitimacy
• For all of the innovation systems, a strong legitimacy for the
positive impacts these new technologies and products could
have on improving food security, climate change resilience and
converting agrowaste into something beneficial.
• At the same time other factors are acting to reduce this
legitimacy, likely based on perceptions, such as;
- some of the potential products associated with poverty,
-Running biogas digesters perceived as dirty and unattractive
.
Resources
• Human resources appear to be adequate to drive the
innovation process forward.
• Financial resources for moving the innovation
process forward towards commercialization and large
scale application is a limiting factor.
• What is promising is that in countries such as
Tanzania, Ethiopia and Kenya, new funding
mechanisms for innovation are under development.
Externalities
• Advocacy groups lacking with an exception of
tissue culture buisness network.
Summary TableInnovation
case
Actors Knowledge
development
Entrepreneu
rial activity
Guidance/
Policies
Market
creation
Getting
legitimacy
Resources Externaliti
es
Avarage
score
Crop improvement
technologies 4 3 2 2 1 3 2 2 2
Value Added products
from Sorghum and
Millet
3 3 2 2 2 3 2 1 2
Bioenergy & mushroom
production from
agroindustrial waste
3 3 2 2 2 3 2 1 2
Industrial Enzymes for a
sustainable Bioeconomy 2 2 1 1 1 3 2 1 2
1=Very Poor, 2=Poor, 3=Fair, 4=Good
Discussion and
Recommendations
Public institutions able to engage in
innovation and technology dissemination
Establishing a Foundation for Innovation and Linking with the Private sector.
technology transfer/dissemination capacities,
institutional IP policies and management capacities
ability to manage collaboration and networking opportunities including engaging in contractual agreements.
Rewarding & Supporting Entrepreneurship
Strengthen entrepreneurial skills at public R&D organizations,
Rules/policies/incentives for being innovative and entrepreneurial such as rewards, competitive salaries, career development opportunities, etc
Encourage the development of public R&D spin-off companies;
Creating Links
Strengthening public–private partnerships
– Supporting public and private actors to meet and discuss collaboration
opportunities, technology transfer, adaptation and commercialization of
public R&D.
Business incubation services
– Business case development, viability analysis and strategy refinement
– Market assessment and market access
– Business model validation and market testing
– Technology assessment (incl. IP assessment)
– Business plan development (feasibility; strategies)
– Assisting in finding financing sources for development and
commercialization
Policies, strategies, communication
Policies, regulations at national and regional
level should be supportive
Clear goals, sufficient incentives, and
strategies necessary
Communicating effectively
Funding R&D and Innovation
• Government innovation funds. The donor community can complement and strengthen government innovation funds.
• Venture capital.
• Attracting more philanthropic investments.
• Providing incentives for local private sector investment in research.
Conclusion• The actors and all functions in the four sub-innovations
systems and how they perform are weak. An exception to this is the case on micropropagation of disease free cassava, sweet potato and potato which is a more mature field of innovation and where many of its functions are stronger.
• A visible pattern, although not very distinctive, is that the number of actors involved in the systems and knowledge formation is improving in all the cases, with the exception of industrial enzymes.
• The Bio-Innovate programme has most probably been an important factor behind this improvement.
• Thus, need to make these innovation systems more effective, a more pronounced focus and investment on improving market potentials, policies and resources for these systems would be more effective than strengthening R&D efforts.
Acknowledgement
• Bio-Innovate/Sida
• Bio-Innovate Project Teams
Thank you